DAX breaks 9300

The German equity market has pulled back some of its losses from yesterday but confidence has not fully recovered.

The DAX is trading at 9320, up 0.6%, as traders exhibit caution while waiting for news from Crimea. The uncertainty about the likelihood of war has held back the equity market from heading towards the January highs. If conflict were to break out, or even if speculation grows that it may be imminent, we could see the market return towards the 9200 level.

The European Central Bank revealed its plans to stress-test banks operating in the eurozone. There will be 128 banks under review, and making sure all those operating in the region are well capitalised is essential to the survival of the eurozone. In the long term, stress tests are positive for the banks, as they should instil confidence in the eurozone financial system.

As previously stated, the market is finding support around 9260, while the 9395-9400 level is acting as resistance. 

Germany 30 chart

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.